Diagnostic Cutoff Validation
Diagnostic Cutoff Validation is the methodological process of empirically assessing and confirming the accuracy, reliability, and clinical utility of predefined threshold values used to identify sarcopenia, distinguishing it from other diagnostic procedures by its specific focus on the robustness and generalizability of cutoff points across diverse populations and measurement techniques.
65
Publications
5.9K
Citations
476
Authors
206
Institutions
Publications per year
2017–2026
28
65
Michelle J. Bovin, Brian P. Marx, Frank W. Weathers et al. · Psychological Assessment · 2015 · 2.5K citations · Full text
Christine L.H. Snozek, Eugene P. Chambers, Carl C. Reading et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 171 citations · Full text
Choosing a diagnostic cut‐off for cannabis dependence
Wendy Swift, Jan Copeland, Wayne Hall · Addiction · 1998 · 164 citations
1–5 of 65
476
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 476
206
Charles University
Prague, Czechia
3 h-index
9 publications
427 citations

Sichuan University
Chengdu, China
3 h-index
10 publications
447 citations

Universidad de Murcia
Murcia, Spain
3 h-index
11 publications
244 citations

University of Padua
Padua, Italy
2 h-index
7 publications
598 citations

Peking University
Beijing, China
2 h-index
11 publications
201 citations
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
2 h-index
7 publications
1.9K citations
Ljubljana University Medical Centre
Ljubljana, Slovenia
2 h-index
2 publications
126 citations
Mayo Clinic
Rochester, United States
2 h-index
9 publications
1K citations
1–8 of 206
JCEM · 4 publications · 344 citations
4
h-index
2 publications · 73 citations
2
h-index
JVIM · 2 publications · 108 citations
2
h-index
TCN · 2 publications · 108 citations
2
h-index
2 publications · 487 citations
2
h-index
1–5